HEALTH INTEL: THE SILENT BURDEN OF ANTIMICROBIAL RESISTANCE Antibiotic-resistant infections kill an estimated 1.27 million people globally per year, with projections suggesting 10 million annual deaths by 2050 if current trends continue—potentially exceeding cancer mortality. This crisis stems from decades of overuse: roughly 70% of antibiotics in the US are administered to livestock for growth promotion rather than treating disease, accelerating resistance evolution. Historically, the discovery window for new antibiotics has narrowed dramatically—the last major antibiotic class was developed in 1987, while resistance spreads exponentially faster. Understanding this trajectory matters because routine surgeries, childbirth, and minor infections could revert to pre-antibiotic-era fatality rates within a generation, fundamentally reshaping medical practice and life expectancy globally.